ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

TYO:4886 Revenue

ASKA Pharmaceutical Holdings had revenue of 19.23B JPY in the quarter ending December 31, 2025, with 9.56% growth. This brings the company's revenue in the last twelve months to 68.70B, up 7.43% year-over-year. In the fiscal year ending March 31, 2025, ASKA Pharmaceutical Holdings had annual revenue of 64.14B with 2.06% growth.

• Revenue (ttm): 68.70B
• Revenue Growth: +7.43%
• P/S Ratio: 1.01
• Revenue / Employee: 42.09M
• Employees: 1,632
• Market Cap: 69.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	64.14B	1.30B	2.06%
Mar 31, 2024	62.84B	2.38B	3.94%
Mar 31, 2023	60.46B	3.85B	6.81%
Mar 31, 2022	56.61B	1.43B	2.58%
Mar 31, 2021	55.18B	2.64B	5.02%